Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection

Annals of Surgical Treatment and Research

Volumn 86, Issue 3, 2014, Pages 143-151

  Ryuk, Jong Pil ^a   Choi, Gyu Seog ^a   Park, Jun Seok ^a   Kim, Hye Jin ^a   Park, Soo Yeun ^a   Yoon, Ghil Suk ^b   Jun, Soo Han ^c   Kwon, Yong Chul ^c  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Colorectal neoplasms; Recurrence; Recurrence interval; Risk factors; Survival

Indexed keywords

EID: 84905042239     PISSN: 22886575     EISSN: 22886796     Source Type: Journal    
DOI: 10.4174/astr.2014.86.3.143     Document Type: Article

References (30)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon (FR): International Agency for Research on Cancer; c2014 [cited 2013 Jan 31]. Available from: http://globocan.iarc.fr.
2. Ministry of Health and Welfare. The Korea central cancer registry. Annual Report of Cancer Incidence in 2008. Seoul: Ministry for Health and Welfare; 2010.
3. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 1994; 81: 7-19.
4. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002; 324: 813.
5. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005; 23: 8512-9.
6. Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier AM. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol 2005; 16: 756-61.
7. Longo WE, Johnson FE. The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am 2002; 82: 1091-108.
8. Kaiser AM, Kang JC, Chan LS, Beart RW. The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer. Colorectal Dis 2006; 8: 696-703.
9. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Follow-up of patients with curatively resected colorectal cancer: A practice guideline. BMC Cancer 2003; 3: 26.
10. Lopez-Kostner F, Fazio VW, Vignali A, Rybicki LA, Lavery IC. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 2001; 44: 173-8.
11. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
12. Cho YB, Chun HK, Yun HR, Lee WS, Yun SH, Lee WY. Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection. Dis Colon Rectum 2007; 50: 1204-10.
13. Aghili M, Izadi S, Madani H, Mortazavi H. Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer. Asia Pac J Clin Oncol 2010; 6: 35-41.
14. Tsai HL, Chu KS, Huang YH, Su YC, Wu JY, Kuo CH, et al. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol 2009; 100: 736-43.
15. Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: A multicenter study. Surgery 2007; 141: 67-75.
16. McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts JM, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994; 37: 875-81.
17. Tsai HL, Cheng KI, Lu CY, Kuo CH, Ma CJ, Wu JY, et al. Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection. J Surg Oncol 2008; 97: 383-7.
18. Yakabe T, Nakafusa Y, Sumi K, Miyoshi A, Kitajima Y, Sato S, et al. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer. Ann Surg Oncol 2010; 17: 2349-56.
19. Holubec L Jr, Topolcan O, Pikner R, Pecen L, Holubec Sen L, Finek J, et al. Criteria for the selection of referential groups in tumor marker statistical evaluation on the basis of a retrospective study. Anticancer Res 2003; 23(2A): 865-70.
20. Morita S, Nomura T, Fukushima Y, Morimoto T, Hiraoka N, Shibata N. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer? Dis Colon Rectum 2004; 47: 227-32.
21. Park IJ, Choi GS, Jun SH. Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer. Anticancer Res 2009; 29: 4303-8.
22. Yu H, Son GM, Joh YG. The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer. J Korean Surg Soc 2013; 84: 231-7.
23. Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 1996; 179: 358-69.
24. Fujita S, Shimoda T, Yoshimura K, Yamamoto S, Akasu T, Moriya Y. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection. J Surg Oncol 2003; 84: 127-31.
25. Bentzen SM, Balslev I, Pedersen M, Teglbjaerg PS, Hanberg-Sorensen F, Bone J, et al. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy: A multivariate regression analysis. Br J Cancer 1992; 65: 102-7.
26. Jung SH, Kim HC, Kim AY, Choi PW, Park IJ, Yu CS, et al. colorectal cancer presenting as an early recurrence within 1 year after a curative resection. J Korean Soc Coloproctol 2008; 24: 265-72.
27. Kobayashi H, Mochizuki H, Morita T, Kotake K, Teramoto T, Kameoka S, et al. Timing of relapse and outcome after curative resection for colorectal cancer: A Japanese multicenter study. Dig Surg 2009; 26: 249-55.
28. Yie SM, Lou B, Ye SR, Cao M, He X, Li P, et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 2008; 15: 3073-82.
29. Lee SY, Min KS, Chung JK, Jung IM, Ahn YJ, Hwang KT, et al. Carcinoembryonic antigen level of draining venous blood as a predictor of recurrence in colorectal cancer patient. J Korean Surg Soc 2011; 81: 387-93.
30. Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 2010; 36: 470-6.